Sevaro Health Raises $12 Million Series A Led by Catalyst Investors

Best-in-class teleneurology provider focuses on clinical care optimization by leveraging modern technology, data and clinical workflows.

MARCH 29, 2023 – Best-in-class teleneurology provider Sevaro Health raised a $12 million Series A round of funding led by growth equity firm Catalyst Investors with participation from existing investor APA Venture Partners. Sevaro focuses on clinical care optimization for neurological disorders by leveraging modern technology, data and clinical workflows.

Physician-led and founded in 2019 by Raj Narula, MD, Sevaro solves the administrative, workflow and technology challenges of telehealth to connect patients and hospitals with neurologists in an industry-leading 45 seconds, dramatically improving treatment times, reducing disability and improving outcomes. In doing so, Sevaro addresses the massive problem of delayed stroke care, the fifth leading cause of death in the U.S. and a leading cause of disability. Every 40 seconds someone suffers a stroke, and every four minutes someone dies of a stroke; time to care is vital. Teleneurology, especially telestroke, is an established and accepted telehealth specialty that provides better patient outcomes more efficiently. There are very few cases neurologists cannot address virtually with the help of onsite provider support.

“Telehealth helps bridge the supply and demand imbalance of neurologists, especially vascular neurologists, to improve healthcare access. At Sevaro we have crafted a patient-centric model with an unwavering commitment to provide the highest quality of neurological care, regardless of location,” said Dr. Narula, Chief Executive Officer. “United by an unrelenting passion for transforming healthcare, Sevaro and Catalyst’s vision aligns to put patients and physicians at the heart of every decision we make. We will reshape the future of healthcare, ensuring every patient receives the neurological care they truly deserve.”

“Sevaro has fantastic hospital and patient resonance that they’re committed to scaling in the right way, putting the patient, hospital and providers first to increase healthcare access and improve outcomes nationwide,” said Kapil Desai, partner with Catalyst Investors. “With Raj at the helm, the company has a strong understanding of how to provide data-driven, personalized teleneurology services at scale. We are excited to work with Sevaro to expand ongoing investments in go-to-market, technology and clinical operations including physician recruiting.”

“As an early investor in Sevaro, it has been incredible to witness a team so dedicated to pushing the boundaries of innovation and improving patient outcomes,” said Ajay Sharma, co-founder and managing partner of APA Venture Partners. “We are thrilled to partner with Catalyst to continue to support Sevaro’s mission of revolutionizing neurological care.”

About Sevaro

Sevaro is a data-driven provider of telestroke and teleneurology services to hospitals, healthcare systems and payers. Sevaro maximizes its impact through the use of technology, with an emphasis on compassion. For more information, visit

About Catalyst Investors

Catalyst Investors is a growth equity firm based in New York. Over the past 20-plus years, Catalyst has invested in rapidly growing companies across the SaaS, tech enabled services and internet infrastructure sectors, and has established a successful track record of partnering with entrepreneurs and helping companies scale. Recent investments and exits include Pax8, LinkSquares, Ekos, Breezeway, Rivet, ChowNow, Weave, Clinicient, EDB and PresenceLearning. For more information, visit

About APA Venture Partners

APA Venture Partners is a pre-seed and seed stage venture capital firm, investing in the automation of legacy industries. With significant experience in institutional venture capital and supporting high-growth startups, the firm has a successful track-record of helping founders achieve product market fit. For more information, visit